Search Results - "de Prado Gómez, Lucia"
-
1
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
Published in ERJ open research (01-03-2023)“…Many patients with asthma experience loss of lung function over time, and in certain patients this can lead to progressive obstructive patterns similar to…”
Get full text
Journal Article -
2
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
Published in ERJ open research (01-10-2022)“…Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammatory disease of the nasal and paranasal sinuses. Dupilumab is a monoclonal…”
Get full text
Journal Article -
3
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design
Published in American journal of rhinology & allergy (01-11-2022)“…Background Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are chronic type 2 inflammatory diseases that are frequently associated with each…”
Get full text
Journal Article -
4
Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study
Published in Respiration (01-01-2024)“…Dupilumab is approved for the treatment of severe type 2 (T2) asthma; however, the characteristics of patients receiving dupilumab in routine clinical practice…”
Get more information
Journal Article -
5
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma
Published in American journal of respiratory and critical care medicine (15-04-2024)Get full text
Journal Article -
6
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma
Published in Respiratory medicine (01-11-2023)“…Patients with asthma often experience sleep disturbances. We assessed the 5-item Asthma Control Questionnaire (ACQ-5) score ≥2.5 as a useful threshold to…”
Get full text
Journal Article -
7
Content Validation of Patient-Reported Sleep Measures and Development of a Conceptual Model of Sleep Disturbance in Patients with Moderate-to-Severe, Uncontrolled Asthma
Published in Patient related outcome measures (01-01-2023)“…Sleep disturbance is common in patients with asthma and can lead to subsequent impacts on health-related quality of life (HRQOL). Fit-for-purpose…”
Get full text
Journal Article -
8
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthm
Published in American journal of respiratory and critical care medicine (15-04-2024)Get full text
Journal Article -
9
-
10
-
11
-
12
Prevalence of NSAID-ERD Among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA registry
Published in Journal of allergy and clinical immunology (01-02-2024)Get full text
Journal Article -
13
EValuating trEatment RESponses of dupilumab versus omalizumab in Type 2 patients: the EVEREST Trial
Published in Journal of allergy and clinical immunology (01-02-2022)Get full text
Journal Article -
14
Baseline Characteristics Of Patients With Asthma Treated With Dupilumab In A Real-World Setting: The RAPID Registry
Published in Journal of allergy and clinical immunology (01-02-2023)Get full text
Journal Article -
15
-
16
LONGITUDINAL TRAJECTORY OF LUNG FUNCTION IN PATIENTS WITH UNCONTROLLED ASTHMA
Published in Chest (01-10-2024)Get full text
Journal Article -
17
-
18
DUPILUMAB SAFETY AND EFFICACY IN A REAL-WORLD CLINICAL SETTING: THE RAPID ASTHMA REGISTRY
Published in Chest (01-10-2024)Get full text
Journal Article -
19
BASELINE CHARACTERISTICS AND COEXISTING TYPE 2 INFLAMMATORY DISEASES OF PATIENTS WITH ASTHMA INITIATING DUPILUMAB IN A REAL-WORLD SETTING: THE RAPID REGISTRY
Published in Chest (01-10-2024)Get full text
Journal Article -
20
CHARACTERIZATION OF PATIENTS WITH ASTHMA TREATED WITH DUPILUMAB IN A REAL-WORLD SETTING: THE RAPID REGISTRY
Published in Chest (01-10-2022)Get full text
Journal Article